ginkgo (Ginkgo biloba)
Title: ginkgo (Ginkgo biloba)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 3/5/2019 12:00:00 AM
Publication date: September 2020Source: Biomedical Signal Processing and Control, Volume 62Author(s): Stephanos Leandrou, Demetris Lamnisos, Panicos A. Kyriacou, Stephanie Constanti, Constantinos S. Pattichis, for the Alzheimer's Disease Neuroimaging Initiative
Phys. Chem. Chem. Phys., 2020, Accepted Manuscript DOI: 10.1039/D0CP02459G, PaperShivani Gupta, Ashok Kumar Dasmahapatra The clinical signature of Alzheimer ’s disease (AD) is the deposition of aggregated Aβ fibrils that are neurotoxic to the brain. It is the major form of dementia affecting older people... The content of this RSS Feed (c) The Royal Society of Chemistry
Anti-Amyloid-β Protein agents for the treatment of Alzheimer's Disease: An update on emerging drugs. Expert Opin Emerg Drugs. 2020 Aug 10;: Authors: Lozupone M, Solfrizzi V, D'Urso F, Di Gioia I, Sardone R, Dibello V, Stallone R, Liguori A, Ciritella C, Daniele A, Bellomo A, Seripa D, Panza F Abstract INTRODUCTION: Currently available Alzheimer's disease (AD) therapeutics are only symptomatic, targeting cholinergic and glutamatergic neurotransmissions. Several putative disease-modifying drugs in late-stage clinical development target amyloid-β (Aβ) peptide and tau protein, the principal ...
Authors: Scicutella A PMID: 32772597 [PubMed - as supplied by publisher]
Dementia Research Chatathon - 7 September, 9:00 (GMT+1)For 12 hours the host Adam Smith (@BetterResearch) will be chatting with 55 researchers from all fields of dementia research, using video chat – live streamed using Zoom and YouTube. They will discus their research, the latest hot topics in their field, and how they are working to beat the disease and improve the lives of people affected. This event is open to everyone interested i n finding out more about the latest research taking place on dementia and information will be accessible to researchers, healthcare professionals, and family and carer...
Image analysis services provider Mediaire has launched version 3.0 of its mdbrain...Read more on AuntMinnie.comRelated Reading: SNMMI 2020: Image of the Year scans reveal 'super-agers' New tau PET tracer better targets source of Alzheimer's PET tracer could more precisely diagnose Alzheimer's MRI shows intracranial volume changes through adulthood Smart Reporting, Mediaire to develop MS software
Condition: Alzheimer Disease Intervention: Diagnostic Test: MicRNAs battery kits Sponsor: Shanghai Mental Health Center Not yet recruiting
Conditions: Alzheimer Disease; Dementia Interventions: Drug: 11C-ER176; Drug: [F-18]MK-6240; Drug: Florbetaben; Other: Magnetic Resonance Imaging Sponsor: Jose Gutierrez Not yet recruiting
The personality changes came ahead of more obvious behavioural changes linked to Alzheimer's. → Support PsyBlog for just $5 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
It is possible to tailor the frequency of laser light to selectively disrupt the bonds or structure of particular arrangements of molecules - such as, say, the harmful protein aggregates found in neurodegenerative and other age-related conditions. Researchers here showcase early work into the disruption of amyloids, a class of altered of proteins that feature prominently in numerous conditions. The challenge in this sort of approach is usually not that of achieving the desired disruption, but rather doing so without the delivery of so much energy, released as heat, that the process kills surrounding cells and tissues. Past...